A study has shown that community pharmacist‐led interventions contribute to improved adherence and better disease control.
Optimal medication adherence is often deemed crucial for the success of a patient’s treatment, as suboptimal adherence may lead to treatment failure and unnecessary medical expenditure. Increasing evidence has highlighted the positive contribution community pharmacist‐led interventions can have on improving patients’ adherence and health outcomes.
This study aimed to provide an overview of the published literature on community pharmacist‐led interventions and their effectiveness in improving patients’ adherence and health outcomes.
The authors developed a search strategy, aimed at retrieval of published reports of community pharmacy interventions worldwide. Medline, EMBASE, International Pharmaceutical Abstracts, Google Scholar and ProQuest Dissertations and Theses databases were searched. Articles meeting the inclusion criteria were collated, relevant data extracted, and a risk of bias assessment undertaken.
The study found that community pharmacist‐led interventions have been shown to improve patients’ adherence and contribute to better blood pressure control, cholesterol management, chronic obstructive pulmonary disease and asthma control. Studies in this review, however, did not report statistically significant effects of interventions on diabetes or depression control.
The authors concluded that community pharmacist‐led interventions have been shown to contribute to improved adherence and better disease control. Future research should attempt to better understand which particular intervention components make the greatest contribution towards improving adherence and health outcomes, for patients with different medical conditions.